Translational individualised medicine: inflammation and cancer

Group leader

Melchor Álvarez de Mon Soto

melchor.alvarezdemon(ELIMINAR)@uah.es

Tlf.: +34 91 885 45 98

Collaborators

  • Jorge Monserrat Sanz
  • Manuel Miguel Rodríguez Zapata
  • Susana Nuñez Nagy
  • Alfredo Prieto Martin
  • Eva María Sanz Merino
  • Julio García Suárez
  • Mónica Arroyo Yustos
  • Fátima Navarro Éxposito
  • Raquel Molina Villaverde
  • Cristina Bohorquez Heras
  • Laura Villalobos León
  • Atusa Movasat Hajkhan
  • Mercedes Rodríguez Rodríguez
  • Ana Isabel Sánchez Atrio
  • José Barbarroja Ecudero
  • David Díaz Martín
  • José Luis López González
  • Darío Antolín Amérigo

Group leader

Melchor Álvarez de Mon Soto

melchor.alvarezdemon(ELIMINAR)@uah.es

Tlf.: +34 91 885 45 98

Collaborators

  • Jorge Monserrat Sanz
  • Manuel Miguel Rodríguez Zapata
  • Susana Nuñez Nagy
  • Alfredo Prieto Martin
  • Eva María Sanz Merino
  • Julio García Suárez
  • Mónica Arroyo Yustos
  • Fátima Navarro Éxposito
  • Raquel Molina Villaverde
  • Cristina Bohorquez Heras
  • Laura Villalobos León
  • Atusa Movasat Hajkhan
  • Mercedes Rodríguez Rodríguez
  • Ana Isabel Sánchez Atrio
  • José Barbarroja Ecudero
  • David Díaz Martín
  • José Luis López González
  • Darío Antolín Amérigo

Strategic objectives

  • Analysis and characterisation of the immune system response to inflammatory pathogenesis diseases.
  • Clinical and therapeutic significance of changes in the immune system in inflammatory pathogenesis diseases.
  • Development of diagnostic and therapeutic individualised strategies in immune pathogenesis diseases and immunomodulatory treatments.

Research lines

  • Study the alterations of T and B cell compartments and those of cells of the innate response in diseases with an established immunoinflammatory pathology. With special emphasis on autoimmune diseases with compromised musculoskeletal and systemic components. Analysis of the diagnostic and therapeutic significance.
  • Study of the pathogenic participation of the immune system in diseases related with a compromised central nervous system. Analysis of the clinical and therapeutic significance. Development, study and use of biomaterials as tissue substitutes.
  • Research of the etiopathogenic mechanisms of immune system alterations. Analysis of the significance of interactions with the microbiota and with other systems of the organism.
  • Clinical and therapeutic applications of the modulation of the immune system.

Location

Department of Medicine and Medical Specialities


Faculty of Medicine and Health Sciences
Alcalá University
A-2 Km 33,600
28805 Alcalá de Henares (Madrid)
+34 91 885 4598

Link to UAH group

Keywords

T cells, B cells, myelomonocytic cells, inflammation, immunomodulation